St. Louis, MO (PRWEB) September 14, 2015
The FDA issued a new warning statement on the pharmaceutical drug Invokana yesterday.* Attorneys handling Invokana claims for the Onder Law Firm provide the following commentary on the updated warning information:
“The first FDA warning on Invokana focused on the risk of ketoacidosis, a condition where high blood acid levels can result in some serious health conditions, according to the FDA.* FDA’s warning on Invokana which was issued yesterday brings forth an entirely different issue with the drug.
“This new warning from the FDA states that patients taking Invokana face a risk of bone fracture and decreased bone mineral density. The FDA warning states that patients taking Invokana may experience fracture in just 12 weeks after starting to take the drug. The drug’s warning label and adverse reaction list have been adjusted to reflect the new information, according to the FDA.
“When the first FDA warning on Invokana was issued in May of this year, the public had its first indication that taking Invokana for type II diabetes was not without risks. The first Invokana lawsuits were filed soon after. This is a typical pattern when an FDA alert goes public. People who experienced one isolated event begin to realize their situation was part of a larger pattern. And that is when people begin to step forward.
“Having represented American individuals and families in the aftermath of countless drug recalls and safety warnings, our firm is aware of the very serious nature of dangerous drug claims. We have committed our firm’s extensive resources to offering the best legal representation available to persons who believe they may have grounds for an Invokana lawsuit.”
Nationally-renowned attorneys in the realm of family and product liability law, these attorneys provide information and free case reviews for persons wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, heart attack, and wrongful death allegations.
The first FDA Safety Announcement, entitled, “FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood”, was released on May 15, 2015.** In it, the FDA cautioned that Invokana and other sodium-glucose cotransporter-2 inhibiting drugs can result in an unsafe buildup of ketones, or acids, in the blood. The safety communication referred to ketoacidosis as “a serious condition” that “may require hospitalization”.* The symptoms of ketoacidosis include difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness.* According to the FDA, Invokana and other drugs in the SGLT2 class are approved for use to treat type 2 diabetes in adults.
Bone safety and the risk of bone fracture from Invokana was been a subject of FDA concern and investigation since March of 2013, when Invokana was first approved for sale in the U.S., according to an FDA press release from the time.*** The safety report issued yesterday is the outcome of more than two years of investigation.
These Invokana attorneys are currently reviewing claims for kidney problems, ketoacidosis, and other serious health problems connected with Invokana. Invokana lawyers will provide a confidential case evaluation at no charge for persons who suffered kidney failure, blood acid problems, or another side effects while taking Invokana. Individuals who fit this description may contact a lawyer through the firm’s website for a no-obligation consultation on whether they have grounds for an Invokana lawsuit. The firm’s Invokana lawyers believe persons and the family members of persons who meet this description may be entitled to real compensation for the harm and damages they sustained while the makers and manufacturers of Invokana benefited from their business.
The Onder Law Firm welcomes Invokana lawsuit inquiries from law firms in regards to handling them or working as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from Invokana attorneys at http://www.InvokanaKetoacidosisLawsuitCenter.com.
*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm461876.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery, “Invokana and Invokamet (canagliflozin): Drug Safety Communication - New Information on Bone Fracture Risk and Decreased Bone Mineral Density”, 9/10/15
** fda.gov/downloads/Drugs/DrugSafety/UCM446954.pdf 5/15/15
***http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htm “FDA approves Invokana to treat type 2 diabetes” 3/29/13